Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

Topic: Chronic

Monday, 23 October 2017

This month’s Back to Basics feature is a useful wallchart showing the five key functions of the kidney which include making balancing salt and water levels, making strong bones, boosting the production of red blood cells, controlling blood pressure and excreting waste from the blood.

Category: Back to Basics
Wednesday, 21 October 2015

Chronic kidney disease (CKD) is the term used to describe long-lasting abnormal kidney function and/or structure. It is common and often exists together with other conditions like cardiovascular disease (CVD) and diabetes. CKD is an essential diagnosis because treatment can reduce the risk of CVD and prevent or slow progression to kidney failure. This is your briefing on important NICE guideline changes that will help us to better identify at-risk patients while making over-diagnosis less likely.

Category: Editorial
Wednesday, 21 February 2018

This article seeks to demonstrate the close relationship between cardiovascular disease and chronic kidney disease (CKD). It also highlights the importance of identifying people with CKD as a means of recognising people at high risk of both cardiovascular events and unplanned admissions.

Category: Editorial
Wednesday, 04 January 2017

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending extension of the label for all metformin-containing products to included patients with stable moderate renal failure (chronic kidney disease stage 3).

Category: Have You Heard
Tuesday, 23 January 2018

Ischaemic or coronary heart disease is the single leading cause of death in any Western population but more critically is one of the leading causes of premature deaths (i.e. deaths < 75 years) in both men and women. There are numerous risk factors for ischaemic heart disease and understanding these and other comorbidities is critical to achieving optimal outcomes.

Category: Editorial
Sunday, 13 August 2017

The European Commission has approved patiromer (Veltassa®) for the treatment of hyperkalaemia, which marks the first new drug licenced specifically for the treatment of hyperkalaemia in over 60 years.

Category: Have You Heard
Friday, 15 September 2017

Healthcare professionals should offer statins to millions of people with chronic kidney disease (CKD) to help to manage their increased risk of cardiovascular disease (CVD), according to new guidance from NICE.

Category: Have You Heard

Article search and filter